Compare · CNMD vs FONR
CNMD vs FONR
Side-by-side comparison of CONMED Corporation (CNMD) and Fonar Corporation (FONR): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CNMD and FONR operate in Biotechnology: Electromedical & Electrotherapeutic Apparatus (Health Care), so they compete in similar markets.
- CNMD is the larger of the two at $3.95B, about 38.7x FONR ($102.2M).
- Over the past year, CNMD is down 24.5% and FONR is up 55.7% - FONR leads by 80.1 points.
- FONR has been more active in the news (3 items in the past 4 weeks vs 2 for CNMD).
- CNMD has more recent analyst coverage (14 ratings vs 0 for FONR).
- Company
- CONMED Corporation
- Fonar Corporation
- Price
- $38.41+2.52%
- $18.84+0.16%
- Market cap
- $3.95B
- $102.2M
- 1M return
- +3.74%
- +1.54%
- 1Y return
- -24.48%
- +55.66%
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Exchange
- NYSE
- NASDAQ
- IPO
- 1987
- 1981
- News (4w)
- 2
- 3
- Recent ratings
- 14
- 0
CONMED Corporation
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for minimally invasive procedures worldwide. It offers orthopedic surgery products, including sports medicine products comprising powered resection instruments, arthroscopes, reconstructive systems, tissue repair sets, and metal and bioabsorbable implants, as well as related disposable products and fluid management systems; powered surgical instruments for use in bone orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries; sports biologics and tissue products; and surgical visualization products. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.
Fonar Corporation
FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates through two segments, Medical Equipment segment, and Physician Management and Diagnostic services segment. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters and the development and implementation of practice growth and marketing strategies. The company owns and operates 5 diagnostic imaging facilities in Florida; and manages 39 MRI scanning facilities, including 25 facilities located in New York and 14 situated in Florida. It markets its scanners to private diagnostic imaging centers and hospitals. The company was incorporated in 1978 and is based in Melville, New York.
Latest CNMD
- SEC Form DEFA14A filed by CONMED Corporation
- SEC Form DEF 14A filed by CONMED Corporation
- SEC Form 4 filed by Beyer Pat
- CONMED Corporation to Announce First Quarter 2026 Financial Results on April 29, 2026
- Amendment: SEC Form SCHEDULE 13G/A filed by CONMED Corporation
- Amendment: SEC Form 4 filed by Lalomia Brent
- Amendment: SEC Form 4 filed by Schabacker Matthew
- Amendment: SEC Form 4 filed by Foust Hollie K
- Amendment: SEC Form 4 filed by Ferrell John D.
- Amendment: SEC Form 4 filed by Shagory Peter K
Latest FONR
- Amendment: SEC Form SC 13E3/A filed by Fonar Corporation
- SEC Form DEFM14A filed by Fonar Corporation
- Amendment: SEC Form SCHEDULE 13G/A filed by Fonar Corporation
- Amendment: SEC Form SCHEDULE 13G/A filed by Fonar Corporation
- Amendment: SEC Form SC 13E3/A filed by Fonar Corporation
- SEC Form PRER14A filed by Fonar Corporation
- SEC Form SC 13E3 filed by Fonar Corporation
- SEC Form PREM14A filed by Fonar Corporation
- SEC Form DEFA14A filed by Fonar Corporation
- Fonar Corporation filed SEC Form 8-K: Results of Operations and Financial Condition